Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congo poised to mobilise diagnostics in face of "high-mortality unknown illness":

This article was originally published in Clinica

Executive Summary

International epidemiology experts are awaiting the results of laboratory tests on samples related to an "unknown high-mortality" disease in the Democratic Republic of Congo. Healthcare and surveillance teams from the health ministry and the Institut National de Recherches Biologiques, backed by the WHO, are investigating the situation, which is centred in Kasai Occidental province. The exact number of cases and deaths is not yet known, according to a WHO notice, dated August 31, but the majority involves infants under the age of 10, presenting with fever, headache, diarrhoea/abdominal pain and vomiting. The Global Outbreak Alert and Response Network (GOARN) and the WHO are supporting the government's epidemiological investigations and logistics efforts.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049630

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel